CD8A and COVID-19: discovered that the magnitude of spike-specific CD4+ and CD8+ T cell responses to Omicron B.1.1.529 was mostly sustained and similar to those of Beta and Delta variants in COVID-19 convalescent patients and participants with vaccination of Ad26.CoV2.S or BNT162b2 (26).